PACS Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against PACS Group, Inc.- Contact Kessler Topaz Meltzer & Check, LLP

Core Viewpoint - A securities class action lawsuit has been filed against PACS Group, Inc. for allegedly making materially false and misleading statements regarding its business operations and financial performance during the Class Period from April 11, 2024, to November 5, 2024 [1][3]. Group 1: Allegations Against PACS Group - The lawsuit claims that PACS engaged in a scheme to submit false Medicare claims, which accounted for over 100% of its operating and net income from 2020 to 2023 [3]. - It is alleged that PACS billed for thousands of unnecessary respiratory and sensory integration therapies to Medicare [3]. - The company is accused of falsifying documentation related to licensure and staffing, leading to misleading positive statements about its business prospects [3]. Group 2: Legal Process and Participation - Investors in PACS have until January 13, 2025, to seek appointment as lead plaintiff, representing the class in the litigation [4]. - A lead plaintiff is typically the investor or small group of investors with the largest financial interest in the case [4]. - Participation as a lead plaintiff does not affect the ability of other investors to share in any recovery from the lawsuit [4].